Central Modulation of Selective Sphingosine-1-Phosphate Receptor 1 Ameliorates Experimental Multiple Sclerosis

Future treatments of multiple sclerosis (MS), a chronic autoimmune neurodegenerative disease of the central nervous system (CNS), aim for simultaneous early targeting of peripheral immune function and neuroinflammation. Sphingosine-1-phosphate (S1P) receptor modulators are among the most promising d...

Full description

Saved in:
Bibliographic Details
Published in:Cells
Main Authors: Musella, Alessandra, Gentile, Antonietta, Guadalupi, Livia, Rizzo, Francesca Romana, De Vito, Francesca, Fresegna, Diego, Bruno, Antonio, Dolcetti, Ettore, Vanni, Valentina, Vitiello, Laura, Bullitta, Silvia, Sanna, Krizia, Caioli, Silvia, Balletta, Sara, Nencini, Monica, Buttari, Fabio, Stampanoni Bassi, Mario, Centonze, Diego, Mandolesi, Georgia
Format: Artigo
Language:Inglês
Published: MDPI 2020
Subjects:
Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC7291065/
https://ncbi.nlm.nih.gov/pubmed/32455907
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cells9051290
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items